European Biotech Crossroads

Lille, France (November 28-30, 2005)

The next European Biotech Crossroads will combine:

A trade show, with 300 exhibitors and 4000 professional visitors. A seminar programme, with 40 workshops, delivered by 180 international key-note speakers, and organized around 5 tracks: Business development & Biotech economy | Science | Biotech applications in the chemistry, energy, agrofood & environmental fields | Tech transfer, Intellectual Property, Regulatory issues | Careers & talents. Biogenda™, the partnering convention. Biogenda™ gathers 400 companies in the biotechnology, pharmaceutical and financial sectors, offering pre-scheduled one-on-one meetings. Each company will get about 8 meetings per day. Biogenda™ is the business and tech transfer partnering convention which will enable you to: prepare your meetings with your clients and partners and know precisely about their expectations and requirements, select potential partners, etc.

More than 100 companies have already confirmed their participation to Biogenda™ such as: Amgen, Almirall Prodesfarma, Genzyme, F. Hoffmann-La Roche, Institut Pasteur, Oncodesign, Novozymes, Laboratoires Pierre Fabre, Sanofi-Aventis, Zambon Group, etc.

More: http://www.efb-central.org/index.php/Main/european_biotech_crossroads